News

You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have such strong underlying business prospects that they're practically unstoppable.

Three

Image source: The Motley Fool.

UnitedHealth Group (NYSE: UNH)Q4 2024 Earnings CallJan 16, 2025, 8:45 a.m. ET

Operator

Continue reading

Source Fool.com

Shares of UnitedHealth Group (NYSE: UNH) were pulling back Thursday after the company delivered underwhelming fourth-quarter results, as sales were weaker than expected and its costs rose.

 As of

Some investors believe you make money when you buy a stock, not when you sell it. The logic behind this idea is that investing in the right stock at the right time -- and holding onto it for a while

It usually doesn't matter if you buy a given stock immediately or two weeks later. Sure, the stock could move up or down but typically not enough to matter all that much.

However, there are

Stocks tend to perform well in January, but that's not a good reason to invest this month. Strong returns aren't made in a single 30-day period. Instead, as long-term investors know, the key is to

Medicine is the cornerstone of healthcare. That remains true today, with a global pharmaceutical industry valued at $1.4 trillion and expected to grow at 6.1% annually through 2030. In this light

Dividend stocks trading at discounted prices can make for great investments if you're willing to be patient. That's because, assuming their payouts are sustainable, you can lock in a higher yield

If you're a retiree looking for dependable and reliable dividend income, there are many quality stocks out there that can be suitable options for your portfolio. The stocks I've listed below pay

High-yield dividend stocks may not appeal to some investors. However, if you're among those investors looking for income, stocks that pay dividends regularly can be great additions to your

If you're looking for a top dividend stock to own, you want to be sure to consider whether it increases its payout and keep track of how quickly it normally does so. The rate of increases can be key

As we enter 2025, many growth stocks are trading at high valuations and could be running out of room to rise in the near term. For long-term investors, now may be a good time to reevaluate the

For not just years but decades, Medtronic (NYSE: MDT) has proven to be a reliable dividend growth stock to own. The medical device maker has been increasing its payout regularly, and with a yield of

The past year was a great one for the stock market as a whole, but there were plenty of companies that didn't do well in 2024. Shares of Celsius Holdings (NASDAQ: CELH), DexCom (NASDAQ: DXCM), and

When it comes to dividend investing, there are two basic paths you can take. You could seek out businesses that are raising their payouts at a rapid pace, but these stocks tend to offer low yields

Pfizer (NYSE: PFE) stock investors are curious about the valuation and prospects for the healthcare company.

*Stock prices used were the afternoon prices of Jan. 1, 2025. The video was published on

With shares of the popular dividend exchange-traded fund (ETF) Schwab US Dividend Equity ETF (NYSEMKT: SCHD), investors are wondering whether it is time to dump the ETF or double up. In today's

Now that we've shut the door on 2024, it's useful to look back at some of the best -- and, on the flip side, some of the worst -- performers of the year on the stock market. Many outliers were in

No one knows for sure what the new year will hold for the market. However, some stocks' chances for success look particularly good.

We asked three Motley Fool contributors to pick healthcare stocks

Novo Nordisk (NYSE: NVO) and AstraZeneca (NASDAQ: AZN) are among the largest companies in the pharmaceutical industry. Both have generally produced strong financial results in 2024, but one wouldn't

If you're worried about having enough passive income to maintain your lifestyle during retirement, you're not alone. Having to spend more just to maintain their current standard of living is a

Shares of UnitedHealth Group (NYSE: UNH) were pulling back in December due to a backlash against the company following the murder of one of its executives and reports of a potential crackdown on

Pfizer (NYSE: PFE) is an interesting healthcare company with excellent prospects for cash flow growth.

*Stock prices used were the afternoon prices of Dec. 31, 2024. The video was published on Jan

Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) started 2024 on a strong note and performed well through the first half of the year. However, the drugmaker has since seen its shares decline

The stock market enjoyed a strong year in 2024 as the S&P 500 hit new records. The challenge for investors looking to get into the market amid such a strong bull run, however, is that valuations